Defiance Autism Impact ETF (ASD)
NASDAQ: ASD · Real-Time Price · USD
28.08
-0.18 (-0.64%)
Aug 24, 2026, 4:00 PM EDT - Market closed

ASD Holdings Information

ASD is an equity ETF with a total of 41 individual holdings. The top holdings are Definium Therapeutics stock at 4.22%, Neuren Pharmaceuticals at 4.21%, LifeStance Health Group at 3.38%, Otsuka Holdings at 3.32%, and ACADIA Pharmaceuticals at 3.27%.

Total Holdings
41
Top 10 Percentage
33.39%
Asset Class
Equity
ETF Category
Health
Assets
1.41M
PE Ratio
15.78

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1DFTXDefinium Therapeutics, Inc.4.22%1,370
2ASX: NEUNeuren Pharmaceuticals Limited4.21%3,554
3LFSTLifeStance Health Group, Inc.3.38%3,838
4TYO: 4578Otsuka Holdings Co., Ltd.3.32%600
5ACADACADIA Pharmaceuticals Inc.3.27%1,544
6AVXLAnavex Life Sciences Corp.3.24%13,216
7ACHCAcadia Healthcare Company, Inc.3.03%1,328
8BMRNBioMarin Pharmaceutical Inc.3.00%594
9RGENRepligen Corporation2.96%248
10RVTYRevvity, Inc.2.76%326
11JSE: LHCLife Healthcare Group Holdings Limited2.70%53,486
12BWAYBrainsWay Ltd.2.69%2,250
13BMYBristol-Myers Squibb Company2.66%580
14SWX: ROPRoche Holding AG2.66%82
15STO: MCOV.BMedicover AB (publ)2.65%1,496
16ABBVAbbVie Inc.2.61%146
17BFAMBright Horizons Family Solutions Inc.2.60%506
18JNJJohnson & Johnson2.59%138
19TLV: TEVATeva Pharmaceutical Industries Limited2.56%962
20LON: PSONPearson plc2.53%2,182
21TYO: 4502Takeda Pharmaceutical Company Limited2.51%1,000
22JAZZJazz Pharmaceuticals plc2.51%140
23SUPNSupernus Pharmaceuticals, Inc.2.50%726
24LLYEli Lilly and Company2.46%28
25SWX: NOVNNovartis AG2.40%218
Showing 25 of 41 holdings
Subscribe to see the full list
As of Aug 12, 2026